Vitamin B12 is the only vitamin that no plant, animal, or fungus can make on its own. Its synthesis is confined entirely to certain bacteria and archaea, a restriction that ripples through ocean food webs, livestock nutrition, and human dietary choices alike.1PubMed Central. Microbial production of vitamin B12: a review and future perspectives The molecule itself is staggeringly complex, and the evolutionary reasons behind this prokaryotic monopoly touch on everything from Antarctic phytoplankton blooms to why your spirulina supplement probably isn’t doing what you think it is.
Why No Plant or Animal Can Synthesize B12
B12, or cobalamin, is a cobalt-containing molecule with a modified tetrapyrrole ring structure. It is one of the most complicated small molecules found in nature, requiring roughly 30 enzymatic steps to assemble.2PubMed Central. The requirement for cobalt in vitamin B12: A paradigm for protein metalation The sheer complexity of that biosynthetic machinery helps explain why eukaryotes never evolved the pathway independently. Genomic analyses of algae, plants, and animals consistently find no trace of the genes needed for de novo B12 production.3Oxford Academic. Insights into the Evolution of Vitamin B12 Auxotrophy from Sequenced Algal Genomes Instead, every organism that needs B12 either gets it from prokaryotic partners, eats something that already contains it, or has evolved workarounds that let it bypass the vitamin entirely.
Two distinct biosynthetic routes exist within prokaryotes: an aerobic pathway and an anaerobic one. Both start from the same five-carbon precursor and converge on the same final product, but they differ in the middle steps, particularly in when cobalt gets inserted into the ring and whether oxygen is required.4Biochemical Society Transactions. Biosynthesis of cobalamin (vitamin B12) The anaerobic route remains only partially characterized because its intermediates are unstable in the presence of oxygen, which makes laboratory study difficult.5PubMed. The anaerobic biosynthesis of vitamin B12 This dual-pathway system means that B12 producers show up in wildly different environments, from oxygenated surface waters to the oxygen-free interior of a cow’s rumen.
Which Microbes Actually Produce B12
The ability to make B12 is scattered across the microbial tree of life, but it is far from universal even among prokaryotes. Many bacteria and archaea are themselves B12 auxotrophs, meaning they need the vitamin but cannot make it. The producers tend to be specific lineages rather than entire phyla, and the dominant producers shift depending on the environment.
In coastal marine systems, the cast of B12-producing characters changes with the seasons. During productive winter months, archaea in the genera Nitrosopumilus and Nitrosopelagicus dominate B12 synthesis through the anaerobic pathway. In spring and summer, Alphaproteobacteria take over, using the aerobic pathway instead. Cyanobacteria contribute from spring through autumn, but what they produce is mostly pseudo-cobalamin, a related molecule that functions differently.6PubMed. Functional redundancy of seasonal vitamin B12 biosynthesis pathways in coastal marine microbial communities This seasonal relay ensures a near-continuous supply of B12 in the water column, though the form of the vitamin available to algae and other organisms fluctuates throughout the year.
In the Southern Ocean around Antarctica, the picture narrows. Researchers identified a specific gammaproteobacterial group, Oceanospirillaceae ASP10-02a, as the major contributor to cobalamin biosynthesis gene expression in surface waters. This group showed elevated activity in genes related to organic matter acquisition and cell surface attachment, consistent with a mutualistic lifestyle in which it depends on phytoplankton-derived organic carbon to fuel its B12 production.7PubMed Central. Phytoplankton-bacterial interactions mediate micronutrient colimitation at the coastal Antarctic sea ice edge The bacteria get food; the algae get their vitamin. The partnership is intimate and ecologically consequential.
When Two Auxotrophs Team Up to Make B12
One of the more surprising recent findings is that even bacteria that cannot individually synthesize B12 can sometimes collaborate to produce it. In a 2024 study, researchers showed that a Colwellia species and a Roseovarius species, both B12 auxotrophs on their own, could cooperate by exchanging building blocks. Colwellia synthesized and released an activated lower ligand, while Roseovarius used it to assemble the corrin ring and complete the B12 molecule. Strikingly, Roseovarius released the finished B12 only in co-culture with Colwellia and only when a prophage encoded in its genome was induced, suggesting the B12 release was tied to viral lysis rather than active secretion.8Nature. Ligand cross-feeding resolves bacterial vitamin B12 auxotrophies
This cross-feeding phenomenon may be widespread. In tropical Atlantic waters, bacteria predicted to be capable of salvaging only part of the B12 molecule outnumber complete B12 producers.8Nature. Ligand cross-feeding resolves bacterial vitamin B12 auxotrophies The implication is that the ocean’s B12 supply does not come solely from solo producers churning out the finished vitamin. A significant fraction may be assembled piecemeal by microbial communities, with different species contributing different fragments. That makes B12 production a communal project, not just an individual metabolic feat.
B12 as an Invisible Lever in Ocean Productivity
Because phytoplankton sit at the base of marine food webs and many of them need B12, the vitamin can limit primary productivity in ways that are easy to overlook. In the Ross Sea, bottle incubation experiments showed that adding both iron and B12 together produced higher phytoplankton growth than adding iron alone. The experiments where B12 made a difference were the ones that started with lower bacterial abundances, consistent with the idea that bacteria are the phytoplankton’s main B12 source and that fewer bacteria means less vitamin available.9Limnology and Oceanography. Vitamin B12 and iron colimitation of phytoplankton growth in the Ross Sea
At the coastal Antarctic sea ice edge, researchers documented simultaneous cobalamin and iron limitation of phytoplankton communities. Diatoms, the dominant primary producers, showed gene expression patterns indicative of both iron and B12 deprivation at once.7PubMed Central. Phytoplankton-bacterial interactions mediate micronutrient colimitation at the coastal Antarctic sea ice edge Since Southern Ocean productivity plays a major role in global carbon cycling, the availability of a vitamin made only by bacteria could have indirect effects on atmospheric COâ‚‚ drawdown. The fact that a molecule produced by a handful of microbial lineages can shape planetary-scale biogeochemistry is a striking illustration of how dependent the biosphere is on prokaryotic metabolism.
Why Land Plants Escaped B12 Dependence
Many aquatic algae need B12 for a specific enzyme called B12-dependent methionine synthase, which handles a critical step in the methylation cycle. If an alga loses its gene for the B12-independent version of that enzyme, it becomes locked into needing B12 from bacterial partners. Genomic evidence shows that this loss happened independently in multiple algal lineages. In the green algae Volvox carteri and Gonium pectorale, the gene for the B12-independent enzyme survives only as a nonfunctional pseudogene, suggesting that B12 dependence evolved relatively recently in those groups.3Oxford Academic. Insights into the Evolution of Vitamin B12 Auxotrophy from Sequenced Algal Genomes
Land plants went the opposite direction. They retained the B12-independent methionine synthase, which allowed them to complete the methylation cycle without any cobalamin at all. This enzyme works more slowly than its B12-dependent counterpart, but it freed terrestrial plants from needing a constant bacterial B12 supply.10PubMed Central. Presence of vitamin B12 metabolism in the last common ancestor of land plants This is why no fruit, vegetable, or grain naturally contains meaningful amounts of B12. The plants simply do not use it and have no reason to accumulate it. For herbivores, this means B12 must come from somewhere else entirely: the bacteria in their own guts or in the soil on what they eat.
How Ruminants Solve the B12 Problem
Cattle, sheep, and other ruminants have an elegant solution. Their multi-chambered stomachs house dense communities of bacteria and archaea that synthesize B12 on site, as long as they get enough cobalt from their diet. Cobalt is the essential raw material: it sits at the center of the finished cobalamin molecule, and without dietary cobalt, rumen microbes cannot produce the vitamin. Current recommendations for dairy cattle place the cobalt requirement at roughly 0.20 mg per kilogram of dry matter in the diet.11PubMed Central. Relationship between Vitamin B12 and Cobalt Metabolism in Domestic Ruminant: An Update
The conversion process is inefficient. Only about 3 to 15 percent of dietary cobalt actually ends up as B12, and the efficiency varies depending on what the animal is eating, the ratio of forage to concentrate in the diet, and the composition of the rumen microbial community.12PubMed Central. Cobalt and Vitamin B12 in Dairy Cattle Nutrition: Requirements, Functions, and Interactions In cobalt-poor regions, livestock can develop B12 deficiency even when grazing on abundant pasture. This is ultimately a soil problem: the cobalt content of most soils is usually sufficient to support B12-producing prokaryotes, and the density of B12-producing bacteria in soil is high compared to water bodies. Terrestrial plants accumulate cobalt from the soil and pass it along to the rumen and gut microbes that do the actual B12 synthesis.13SpringerLink (Biology and Fertility of Soils). Soil contribution to the cobalamin (vitamin B12) supply of terrestrial organisms Plants act as cobalt shuttles, not B12 factories.
What B12 Does Once You Absorb It
In humans, B12 serves as a cofactor for two enzymes. Methylcobalamin works with methionine synthase, which transfers a methyl group from folate to homocysteine to regenerate methionine and release usable folate back into circulation. Adenosylcobalamin works with methylmalonyl-CoA mutase in the mitochondria, converting a breakdown product of certain fatty acids into a form that can enter the citric acid cycle for energy production.14PubMed. Biochemistry of B12-cofactors in human metabolism Without enough B12, both pathways stall. Homocysteine accumulates in the blood, folate gets trapped in an unusable form (which is why B12 deficiency and folate deficiency can mimic each other), and methylmalonic acid builds up.
Getting B12 from food into cells is a multi-step relay. In the stomach, peptic digestion frees B12 from the proteins it is bound to in food. It then binds to carrier proteins called R-proteins. In the duodenum, pancreatic enzymes strip B12 from the R-proteins and hand it off to intrinsic factor, a glycoprotein secreted by the stomach lining. The B12-intrinsic factor complex travels to the terminal ileum, where specific receptors absorb it into the bloodstream.15PubMed. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract Any disruption along this chain, from stomach surgery to autoimmune destruction of intrinsic factor-producing cells, can cause deficiency regardless of how much B12 is in the diet.
When deficiency is suspected, measuring serum methylmalonic acid is one of the most sensitive tools available. In a study of over 400 episodes of confirmed cobalamin deficiency, methylmalonic acid levels were elevated in over 98 percent of cases, making it a more reliable marker than B12 blood levels alone.16The American Journal of Medicine. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
The Spirulina Misconception
Spirulina is frequently marketed as a plant-based source of B12, but the claim is misleading. When researchers analyzed spirulina tablets using methods that could distinguish active B12 from look-alike molecules, they found that about 83 percent of the B12-like compounds present were pseudovitamin B12, a form that binds to human intrinsic factor poorly and is not biologically active in human metabolism. Only about 17 percent was genuine vitamin B12.17PubMed. Pseudovitamin B(12) is the predominant cobamide of an algal health food, spirulina tablets Microbiological assays, which cannot distinguish between active B12 and its analogues, overestimated the B12 content by six- to nine-fold compared to more specific methods.
This is a recurring issue with cyanobacterial food products. Cyanobacteria, as noted in the seasonal marine studies above, tend to produce pseudo-cobalamin rather than true cobalamin. The distinction matters for anyone relying on spirulina or chlorella supplements as their sole B12 source. The analogues can even interfere with B12 assays, making a blood test look normal when functional B12 status is actually inadequate. For people on plant-based diets, fortified foods or a dedicated B12 supplement remains the most reliable strategy.
Industrial B12 Production
The complexity of B12’s structure makes full chemical synthesis impractical for commercial purposes. Robert Woodward’s total synthesis in the 1970s remains a landmark achievement in organic chemistry, but it required over 70 steps and is nowhere close to economically viable. As a result, all industrial B12 production relies on microbial fermentation.18PubMed Central. Bioprocess Strategies for Vitamin B12 Production by Microbial Fermentation and Its Market Applications
Two families of microorganisms have dominated industrial production for decades. Strains of Propionibacterium freudenreichii use the anaerobic pathway, while strains related to Pseudomonas denitrificans use the aerobic one.18PubMed Central. Bioprocess Strategies for Vitamin B12 Production by Microbial Fermentation and Its Market Applications Much of the ongoing research in this area focuses on finding better producer strains and optimizing fermentation conditions, including feed composition, oxygen levels, and cobalt supplementation to push yields higher. The B12 produced this way ends up in dietary supplements, fortified foods, livestock feed additives, and pharmaceutical preparations. Every B12 pill you take originated in a bacterial culture.
Biofortifying Plants With B12-Producing Bacteria
Because plants do not make B12, one creative approach has been to let bacteria do the work inside the plant. In a 2025 proof-of-concept study, researchers identified an endophytic bacterium, Methylobacterium sp. strain P1-11, that could live inside lettuce tissue and produce detectable B12 in the living plant. The lettuce accumulated about 1.7 micrograms of B12 per gram of dry weight without cobalt supplementation, and roughly 2.6 micrograms per gram when cobalt chloride was added to the growth medium.19PubMed Central. Lettuce fortification through vitamin B12-producing bacteria – proof of concept study This was the first demonstration that a bacterial endophyte could produce B12 inside a plant, opening a potential route to enhancing the nutritional value of plant-based foods for people on diets low in animal products.
The technology is still in its earliest stages. Questions about scalability, B12 stability through storage and cooking, food safety, and consumer acceptance are all unresolved. But the underlying logic is sound: since only bacteria can make B12, and bacteria can live inside plants, you can potentially turn a lettuce leaf into a B12 delivery vehicle by introducing the right microbial partner. It is a neat inversion of the usual plant-microbe relationship, using the mutualism that already exists in ocean and soil ecosystems and redirecting it toward human nutrition.
Gut Bacteria and Human B12 Status
Your own gut harbors B12-producing bacteria, but their relationship to your B12 status is not straightforward. Most B12-producing activity in the human gut occurs in the colon, well past the terminal ileum where B12 absorption takes place. This means the B12 your gut bacteria make is largely excreted rather than absorbed. Some animals solve this problem through coprophagy, but humans obviously do not.
A preprint analyzing gut microbiome data found an inverse relationship between serum B12 levels and the abundance of potential B12-producing bacteria in the gut. People with B12 deficiency had significantly higher cumulative abundances of B12 producers, and this abundance increased exponentially as serum B12 approached the deficient range.20bioRxiv. The abundance of potential vitamin B12 producers in gut microbiome is inversely associated with serum vitamin B12 levels: A putative role of Host-microbiome feedback regulation The authors proposed a feedback loop in which the host’s low B12 status creates conditions that favor the growth of B12-producing microbes. Whether this microbial B12 ever becomes accessible to the host, and whether any of it gets absorbed through mechanisms other than the classical ileal pathway, remains an open question. The finding is a reminder that having B12-producing bacteria inside you is not the same as benefiting from their output. Geography within the gut matters as much as microbial talent.
The Discovery That Started With Liver
The path to understanding B12 began not with bacteria but with a disease. Pernicious anemia, a fatal condition involving progressive weakness and nerve damage, was recognized throughout the 1800s but had no effective treatment. In 1926, George Minot and William Murphy demonstrated that feeding patients large amounts of liver produced consistent improvement in blood counts and clinical symptoms, a finding that earned them the Nobel Prize.21PubMed. The discovery of vitamin B12 It took another two decades to isolate the actual molecule responsible. B12 was crystallized simultaneously by two groups in 1948, and its three-dimensional structure was solved by Dorothy Hodgkin using X-ray crystallography, contributing to her own Nobel Prize in 1964.21PubMed. The discovery of vitamin B12
In parallel, William Castle’s experiments established the concept of intrinsic factor, demonstrating that something secreted by the stomach was needed for the liver’s “anti-pernicious anemia principle” to be absorbed.22Journal of Gastroenterology and Hepatology. Discovery of vitamin B12 in the liver and its absorption factor in the stomach: A historical review The realization that pernicious anemia was an absorption defect rather than a dietary one transformed how clinicians approached the disease. Today, patients with autoimmune destruction of their intrinsic factor-producing cells receive B12 injections that bypass the gut entirely. The treatment is straightforward once the problem is identified, but the diagnosis can still be tricky, since neurological symptoms sometimes appear long before anemia does.